Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page “Revision” from v3.5.2 to v3.5.3, reflecting a platform/version release rather than any change to the underlying study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:02.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; no study details or outcomes appear to be affected.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:16.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:56.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and the funding-status notice (and Revision: v3.4.1) were removed. These are administrative site updates and do not affect the trial details or eligibility information presented on the page.
    Difference
    0.4%
    Check dated 2026-02-11T11:32:45.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a system-wide funding lapse notice and updated the site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.